{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-116456","form_type":"8-K","ticker":"MTVA","cik":"0001638287","company_name":"MetaVia Inc.","filed_at":"2025-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.018350+00:00","generated_at":"2026-05-16T16:30:30.306051+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MetaVia receives Nasdaq extension to May 2026 to regain minimum bid price compliance","bullets":["Company received Nasdaq approval for 180-day extension to May 26, 2026 to cure bid price deficiency.","Stock closed below $1.00 for 30+ days; compliance deadline originally Nov 25, 2025.","Stockholders previously approved reverse stock split at ratio between 1:5 and 1:30.","If not compliant by May 26, 2026, Nasdaq may delist; company may appeal."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-116456","json":"https://secwatch.observer/filing/0001104659-25-116456.json","markdown":"https://secwatch.observer/filing/0001104659-25-116456.md","text":"https://secwatch.observer/filing/0001104659-25-116456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/mtva-20251126x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:30:30.306051+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"04571c383834fdb15b8e7a81ce03da478feb6e01","claim":"MetaVia Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).","evidence_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","confidence":0.9},{"claim_id":"612a5116dac2a1f76f303996f0d49516b549bd36","claim":"MetaVia Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"May 29, 2025, MetaVia Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a period","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001493152-26-026412","ticker":"CETY","company_name":"Clean Energy Technologies, Inc.","filed_at":"2026-05-29T20:57:27+00:00","headline":"Clean Energy Technologies receives Nasdaq delisting notice for late Q1 filing","event_type":"regulatory","sec_items":["3.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026412","json":"https://secwatch.observer/filing/0001493152-26-026412.json","markdown":"https://secwatch.observer/filing/0001493152-26-026412.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1329606/000149315226026412/0001493152-26-026412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1329606/000149315226026412/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","comparable_excerpt":"May 26, 2026, Clean Energy Technologies, Inc. (the “ Company ”) received a written notice (the “ Notice ”)\nfrom the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not\nin compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) because the Company had not yet filed its Quarterly\nReport on Form 10-Q for the period ended March 31, 2026 (the “ Quarterly Report ”). The\nRule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice has\nno immediate effect on the listing","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1329606/000149315226026412/0001493152-26-026412-index.htm"}},{"accession":"0001628280-26-039190","ticker":"FTHM","company_name":"Fathom Holdings Inc.","filed_at":"2026-05-29T20:15:13+00:00","headline":"Fathom Holdings receives Nasdaq notice for late Q1 2026 10-Q filing; 60 days to submit plan","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039190","json":"https://secwatch.observer/filing/0001628280-26-039190.json","markdown":"https://secwatch.observer/filing/0001628280-26-039190.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1753162/000162828026039190/0001628280-26-039190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1753162/000162828026039190/fthm-20260522.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","comparable_excerpt":"May 22, 2026, Fathom Holdings Inc. (the “Company”) received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission (the “Filing Requirement”). In accordance with Nasdaq’s listing rules, the Company has 60 calendar days from the date of the notification letter","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1753162/000162828026039190/0001628280-26-039190-index.htm"}},{"accession":"0001493152-26-025087","ticker":"LASE","company_name":"Laser Photonics Corp","filed_at":"2026-05-22T21:27:31+00:00","headline":"Laser Photonics receives Nasdaq delisting notice for late Q1 2026 10-Q","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025087","json":"https://secwatch.observer/filing/0001493152-26-025087.json","markdown":"https://secwatch.observer/filing/0001493152-26-025087.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1807887/000149315226025087/0001493152-26-025087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1807887/000149315226025087/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","comparable_excerpt":"received a notice from Nasdaq Listing Qualifications\ndepartment of the Nasdaq Stock Market LLC (“Nasdaq”) stating that since it had not received the Company’s Form 10-Q\nfor the period ended March 31, 2026, the Company does not comply with Nasdaq’s Listing Rules for continued listing. Nasdaq stated\nthat the Company has 60 days to submit a plan to regain compliance with respect to this delinquent report. Nasdaq can grant an exception\nto allow the Company to regain compliance up to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or\nNovember 16, 2026. A\ncopy of t","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1807887/000149315226025087/0001493152-26-025087-index.htm"}},{"accession":"0001628280-26-037742","ticker":"RICK","company_name":"RCI HOSPITALITY HOLDINGS, INC.","filed_at":"2026-05-22T20:23:08+00:00","headline":"RCI receives Nasdaq noncompliance notice for late Q2 10-Q; deadline July 20","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-037742","json":"https://secwatch.observer/filing/0001628280-26-037742.json","markdown":"https://secwatch.observer/filing/0001628280-26-037742.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/935419/000162828026037742/0001628280-26-037742-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/935419/000162828026037742/rick-20260520.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","comparable_excerpt":"May 20, 2026, RCI Hospitality Holdings, Inc. (“we,” “us” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that we are","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/935419/000162828026037742/0001628280-26-037742-index.htm"}},{"accession":"0001731122-26-000781","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-05-22T12:15:26+00:00","headline":"Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026","event_type":"regulatory","sec_items":["3.01","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000781","json":"https://secwatch.observer/filing/0001731122-26-000781.json","markdown":"https://secwatch.observer/filing/0001731122-26-000781.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/0001731122-26-000781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/e7667_8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","comparable_excerpt":"May 20, 2026, Anavex Life Sciences Corp. (the “Company”)\nreceived a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market\nLLC (“Nasdaq”) indicating that, as","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/0001731122-26-000781-index.htm"}},{"accession":"0001493152-26-024913","ticker":"GTBP","company_name":"GT Biopharma, Inc.","filed_at":"2026-05-22T12:00:37+00:00","headline":"GT Biopharma receives Nasdaq extension to Nov 16, 2026 to meet $1 minimum bid price","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-024913","json":"https://secwatch.observer/filing/0001493152-26-024913.json","markdown":"https://secwatch.observer/filing/0001493152-26-024913.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/0001493152-26-024913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","comparable_excerpt":"May 20, 2026, GT Biopharma, Inc., a Delaware corporation (the “Company”), received a letter from the Nasdaq Listing Qualifications\nStaff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/0001493152-26-024913-index.htm"}},{"accession":"0001823878-26-000034","ticker":"MYPS","company_name":"PLAYSTUDIOS, Inc.","filed_at":"2026-05-05T23:59:59+00:00","headline":"PLAYSTUDIOS receives Nasdaq Capital Market transfer; second compliance period to Nov 2, 2026","event_type":"regulatory","sec_items":["3.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001823878-26-000034","json":"https://secwatch.observer/filing/0001823878-26-000034.json","markdown":"https://secwatch.observer/filing/0001823878-26-000034.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823878/000182387826000034/0001823878-26-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823878/000182387826000034/myps-20260505.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","comparable_excerpt":"May 5, 2026, Nasdaq staff approved the Company’s application to transfer its listing to the Nasdaq Capital Market. The transfer will become effective at the opening of business on May 6, 2026 (the “Transfer Date”) and wi","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1823878/000182387826000034/0001823878-26-000034-index.htm"}},{"accession":"0001213900-26-051728","ticker":"HOTH","company_name":"Hoth Therapeutics, Inc.","filed_at":"2026-05-04T23:59:59+00:00","headline":"Hoth Therapeutics receives Nasdaq deficiency notice for minimum bid price non-compliance","event_type":"regulatory","sec_items":["3.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-051728","json":"https://secwatch.observer/filing/0001213900-26-051728.json","markdown":"https://secwatch.observer/filing/0001213900-26-051728.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026051728/0001213900-26-051728-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026051728/ea0288939-8k_hoth.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm","comparable_excerpt":"April 30, 2026, Hoth\nTherapeutics, Inc. (the “Company”) was notified (the “Notification Letter”) by The Nasdaq Stock Market, LLC (“Nasdaq”) that\nit is not in compliance with the minimum bid price requirements set forth i","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026051728/0001213900-26-051728-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}